Earnings estimate | Current qtr. (Sep 2023) | Next qtr. (Dec 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 0 | 3 |
Avg. Estimate | 0 | 0 | 0 | 0.27 |
Low estimate | 0 | 0 | 0 | 0.16 |
High estimate | 0 | 0 | 0 | 0.42 |
Year ago EPS | N/A | N/A | N/A | N/A |
Revenue estimate | Current qtr. (Sep 2023) | Next qtr. (Dec 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
No. of analysts | 1 | 0 | 5 | 3 |
Avg. Estimate | N/A | N/A | 2.97B | 2.83B |
Low estimate | 2.48B | N/A | 3.18B | 2.71B |
High estimate | 2.48B | N/A | 3.42B | 3.02B |
Year ago sales | N/A | N/A | 3.31B | 2.97B |
Sales growth (year/est) | N/A | N/A | -10.30% | -4.80% |
Earnings history | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
---|---|---|---|---|
Est. EPS | N/A | N/A | N/A | N/A |
Actual EPS | N/A | N/A | N/A | N/A |
Difference | N/A | N/A | N/A | N/A |
Surprise % | N/A | N/A | N/A | N/A |
EPS trend | Current qtr. (Sep 2023) | Next qtr. (Dec 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0 | 0.27 |
7 days ago | 0.5 | 0 | 0.22 | 0.27 |
30 days ago | 0.5 | 0 | 0.22 | 0.17 |
60 days ago | 0.5 | 0 | 0.22 | 0.24 |
90 days ago | 0.5 | 0 | 0.22 | 0.3 |
EPS revisions | Current qtr. (Sep 2023) | Next qtr. (Dec 2023) | Current year (2023) | Next year (2024) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | 3 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | FFARM.AS | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | N/A | N/A | N/A | N/A |
Next year | N/A | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | 7.70% | N/A | N/A | N/A |